| Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
| c.94_2169dup | p.Arg723SerfsX21 | Heterozygous | Mutation |
| wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
| TTT | Phe | ins2075a | Fs. | Stop at 743 | Fr. |
| Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
| Actin binding domain |
| At the mRNA level | On restriction map |
| New restriction site(s): none Lost restriction site(s): none |
| On isoforms (a blue cell indicates that the corresponding isoform is affected by the mutation) | ||||||
| Dp 427c | Dp 427m | Dp 427p | Dp 260 | Dp 140 | Dp 116 | Dp 71 |
| Immunofluorescence | ||
| dys 1 | dys 2 | dys 3 |
| Western Blot | ||
| dys 1 | dys 2 | dys 3 |
| Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
| ---406-0-2 | Proband | Female | De novo |
| Phenotypic group |
| Symptomatic carrier |
DYS I |
DYS II |
Myosin |
| DMD carrier - Symptomatic |
| Reference ID | PubMed ID | Reference |
| 8 | 11404124 | Romero NB, De Lonlay P, Llense S, Leturcq F, Touati G, Urtizberea JA, Saudubray JM, Munnich A, Kaplan JC, R*can D. Pseudo-metabolic presentation in a Duchenne muscular dystrophy symptomatic carrier with 'de novo' duplication of dystrophin gene. Neuromuscul Disord. 2001 Jul;11(5):494-8. |